Mei-Yin Polley to Lymphoma, Large B-Cell, Diffuse
This is a "connection" page, showing publications Mei-Yin Polley has written about Lymphoma, Large B-Cell, Diffuse.
Connection Strength
1.259
-
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 2020 06 18; 135(25):2224-2234.
Score: 0.662
-
Two-stage adaptive cutoff design for building and validating a prognostic biomarker signature. Stat Med. 2014 Dec 20; 33(29):5097-110.
Score: 0.445
-
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol. 2019 07 20; 37(21):1790-1799.
Score: 0.152